Founded in 1989, CPC is recognized for its expertise in comprehensive trial management for both national and international clinical research. CPC is led by Dr. William Hiatt, a specialist in vascular medicine, is a professor of Medicine at the University of Colorado and has extensive experience in the design and management of cardiovascular trials. CPC’s Executive Committee has extensive experience in industry, government and academic-sponsored trials. CPC also has considerable regulatory experience, including Dr. Hiatt who recently served as the cardio-renal advisory committee chairman for the FDA.
CPC distinguishes itself from other full service, for-profit CROs:
-
CPC provides leadership in the design and oversight of clinical trials in partnership with our Sponsors. We strive to maximize the success of every clinical trial by integrating sound clinical science, Steering Committee leadership, leading to peer-reviewed publications.
-
CPC has developed a
unique quality intervention designed to minimize endpoint variability. This program allows a sponsor to conduct a more effective trial (less variability translates into more definitive signals, thereby requiring fewer subjects). This quality intervention program includes tailored training videos and reference tools designed to optimize trial conduct. Critical to the success of this program are regular on-site quality interventions with site staff, focusing on their ability to acquire complete and accurate data.
Integrated with our quality interventions, CPC provides:
|
